Skip links

Author: oncologs.com

new-study-further-illuminates-ability-of-cancer-drug-to-lower-blood-sugar

New study further illuminates ability of cancer drug to lower blood sugar

OKLAHOMA CITY, OKLA. – University of Oklahoma researchers have deepened their understanding of a drug’s ability to prevent fat buildup in the liver, a condition that often occurs with obesity and can lead to serious fatty liver disease. Their findings – which illustrate the complexity
modulation-of-senescence-features-using-weo-electrolyzed-water

Modulation of senescence features using weo electrolyzed water

“[…] Weo electrolyzed water could have a positive impact on longevity and age-related diseases.” Credit: 2024 Court-Vazquez et al. “[…] Weo electrolyzed water could have a positive impact on longevity and age-related diseases.” BUFFALO, NY- May 22, 2024 – A new research paper was published
charite-study-in-nature:-how-cells-deal-with-extra-chromosomes

Charité study in Nature: How cells deal with extra chromosomes

Having extra chromosomes is typically an issue for an organism and can disrupt development or cause disease. But some cells benefit instead: For example, cancer cells or pathogenic yeasts can use extra chromosomes to escape treatment and become drug-resistant. A team of researchers from Charité
gz17-6.02-kills-pdx-isolates-of-uveal-melanoma

GZ17-6.02 kills PDX isolates of uveal melanoma

“The present studies demonstrated that GZ17-6.02 interacted with irreversible inhibitors of the EGF receptor and HER2 to kill uveal melanoma cells.” Credit: 2024 Booth et al. “The present studies demonstrated that GZ17-6.02 interacted with irreversible inhibitors of the EGF receptor and HER2 to kill uveal
health-and-economic-benefits-of-breastfeeding-quantified

Health and economic benefits of breastfeeding quantified

Breastmilk can promote equitable child health and save healthcare costs by reducing childhood illnesses and healthcare utilization in the early years, according to a new study published this week in the open-access journal PLOS ONE by Tomi Ajetunmobi of the Glasgow Centre for Population Health,
Explore
Drag